Literature DB >> 19285870

Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity.

Simon J G Lewis1, Roger A Barker.   

Abstract

Parkinson's disease is a common condition with a broad clinical diversity suggesting the existence of distinct subgroups of patients. This paper describes how dopaminergic disruption within basal ganglia circuitry accounts for some of the major features of the disease and examines how the limited repertoire of the output nuclei within these pathways could allow for an element of "cross-talk" between competing inputs. It is proposed that such conditions could lead to an excessive inhibition of the thalamus and pedunculopontine nucleus and account for many of the familiar patterns of clinical phenotype. It is further postulated that this phenomenon may be acting via increased synchronization within the basal ganglia circuitry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285870     DOI: 10.1016/j.jocn.2008.08.020

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  16 in total

1.  Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging.

Authors:  Wang Zhan; Gail A Kang; Graham A Glass; Yu Zhang; Cheryl Shirley; Rachel Millin; Katherine L Possin; Marzieh Nezamzadeh; Michael W Weiner; William J Marks; Norbert Schuff
Journal:  Mov Disord       Date:  2011-08-17       Impact factor: 10.338

2.  Neurotensin inhibits both dopamine- and GABA-mediated inhibition of ventral tegmental area dopamine neurons.

Authors:  Katherine Stuhrman; Aaron G Roseberry
Journal:  J Neurophysiol       Date:  2015-07-15       Impact factor: 2.714

3.  Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus.

Authors:  S H Lee; S S Kim; W S Tae; S Y Lee; J W Choi; S B Koh; D Y Kwon
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

Review 4.  A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson's Disease.

Authors:  Chelsea O'Day; David Isaac Finkelstein; Shanti Diwakarla; Rachel Mai McQuade
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 5.  Review of recent advances in analytical techniques for the determination of neurotransmitters.

Authors:  Maura Perry; Qiang Li; Robert T Kennedy
Journal:  Anal Chim Acta       Date:  2009-09-01       Impact factor: 6.558

6.  Profile of cognitive impairment in late-stage Parkinson's disease.

Authors:  Catarina Severiano E Sousa; Margherita Fabbri; Catarina Godinho; Rita Moiron Simões; Inês Chendo; Miguel Coelho; Isabel Pavão Martins; Joaquim J Ferreira
Journal:  Brain Behav       Date:  2022-03-07       Impact factor: 3.405

7.  Does anxiety cause freezing of gait in Parkinson's disease?

Authors:  Kaylena A Ehgoetz Martens; Colin G Ellard; Quincy J Almeida
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

8.  Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything?

Authors:  J Drouin-Ouellet; R A Barker
Journal:  Stem Cells Int       Date:  2012-12-20       Impact factor: 5.443

9.  The relationships between mild cognitive impairment and phenotype in Parkinson's disease.

Authors:  Jennifer Yy Szeto; Claire O'Callaghan; James M Shine; Courtney C Walton; Loren Mowszowski; Sharon L Naismith; Glenda M Halliday; Simon Jg Lewis
Journal:  NPJ Parkinsons Dis       Date:  2015-08-27

Review 10.  Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.

Authors:  Angie A Kehagia; Roger A Barker; Trevor W Robbins
Journal:  Neurodegener Dis       Date:  2012-10-03       Impact factor: 2.977

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.